Donor Oocyte Supplier Due Diligence: A 7-Step Checklist for Cryobanks

For cryobanks, the quality of a donor oocyte programme depends heavily on the partners behind it. As cross-border collaboration grows between Europe, the UK, the United States, Scandinavia, Australia and Asia, many banks now work with several agencies and clinics at once, often in different regulatory environments. That brings more choice, but it also brings more variability in documentation, screening practices and communication standards.

A structured due diligence process helps a cryobank decide which suppliers to work with, what to ask before onboarding a new partner, and how to keep records consistent over time. This article offers a practical, non-clinical checklist that procurement and quality teams can adapt to their own internal procedures. It is general information only: clinical questions should always be directed to your medical team and partner clinics, and legal or regulatory questions to your own counsel.

Start with the basics. Ask each prospective supplier to explain which authorities oversee their activity and which licences, registrations or accreditations they hold. Depending on the jurisdiction, this might involve a national competent authority, a tissue establishment licence, or a professional accreditation body.

Practical questions to ask include which regulator or authority supervises their donor programme and whether current licence or registration documentation can be shared, when their most recent inspection or audit took place and whether a summary is available, and whether they operate under any regional framework, such as rules that apply to tissues and cells in the EU.

Requirements differ significantly between countries and change over time, so treat the supplier's answers as a starting point. Your own legal and regulatory advisers should confirm whether a given partnership and any cross-border transfer is permissible for your organisation.

A cryobank does not need to replicate a partner's clinical work, but it does need to understand it. Request a written description of the supplier's donor screening workflow, including which categories of assessment are performed and who performs them. You are looking for clarity and consistency rather than marketing language.

Points worth reviewing include whether screening protocols are documented in a standard operating procedure and how often it is reviewed, how donor profiles are structured and how phenotype information and updates are tracked, and how informed consent is obtained, recorded and stored, including whether documentation is available in the languages your clinics require.

Your clinical and quality teams should decide which screening standards your bank requires. The goal of this step is simply to make sure a partner's documentation can be mapped onto your own requirements without gaps.

Traceability is one of the most important areas for any cryobank. Every sample should be linked to a clear record trail from collection through storage and transport. Ask suppliers to walk you through their coding system and how it interacts with yours — what unique identifiers are used and whether they are compatible with any coding standard your bank follows, how records are retained and where, and what happens to records if the supplier changes ownership or ceases operations.

Even well-documented material depends on reliable handling in transit. Ask how shipments are prepared, which courier partners are used, and how temperature monitoring is documented. Many cryobanks request sample shipping records or a description of the supplier's dry-shipper validation process.

Also clarify who is responsible for import and export paperwork and how customs requirements are handled for each destination, what the escalation process looks like if a shipment is delayed, and how the receiving bank is notified at each stage of transport. Import and export rules for reproductive cells vary widely by country, so confirm the specific requirements for each route with your regulatory adviser before committing to a supply arrangement.

Clinics increasingly ask cryobanks for donors that reflect a wide range of backgrounds, and recipient preferences differ from market to market. When assessing a supplier, ask which donor phenotypes they typically work with and how availability is communicated.

Rather than relying on broad claims, ask how phenotype information is recorded, how often availability is updated, and how quickly a supplier can respond to a specific request. Transparent, regularly updated availability tends to reduce back-and-forth for your clinic partners.

Operational fit matters as much as documentation. Consider response times, the languages a supplier works in, and whether there is a named contact for quality questions. Review the contract framework carefully, including responsibilities for each party, dispute resolution, and how changes to donor status are communicated.

Data protection deserves particular attention. Donor information is sensitive, and different regions apply different privacy rules, such as GDPR in the EU and its counterpart in the UK. Ask how personal data is stored, who has access, and how cross-border data transfers are handled. Again, have your own counsel confirm that the arrangement meets the obligations that apply to your organisation.

Due diligence is not a one-time task. Regulations evolve, suppliers change staff and processes, and your own requirements shift as you enter new markets. A simple review cycle helps keep partnerships healthy: schedule periodic document refreshes for licences, SOPs and insurance; keep a shared log of issues, questions and resolutions for each partner; and revisit your checklist whenever you add a new destination market or donor category.

Specialised B2B platforms aim to make supplier discovery and coordination more efficient for professional buyers. DonorMatchPro is a closed platform designed for cryobanks, fertility clinics and donor agencies, bringing verified donor oocyte profiles and professional partners into one workspace. A platform can help organise profiles, structure communication and keep a record of exchanges, but it does not replace your own due diligence, clinical judgement or legal review.

Several other organisations operate in the donor gamete space, including Ovoria, Ovogene and Cryos International, each with its own model and focus. Cryobanks often evaluate a range of options and choose the mix of partners and tools that best fits their markets and internal processes.

Supplier due diligence protects your bank, your clinic partners and ultimately the patients those clinics serve. Focus on regulatory standing, documentation, traceability, logistics, phenotype availability and data protection, and revisit your assessments regularly. For anything clinical, consult your clinic and medical team; for anything legal, regulatory or tax-related, confirm with your own advisers.